手机版 English 帮助中心
外文文献知网节
文献信息节点
基本信息 摘要 关键词 核心评价 相关文献
Journal | [J] 预防医学研究 Volume 4, Issue 8. 2022.
基于乳腺癌免疫逃逸的的作用机制与细胞遗传学分析的 医学研究与卫生经济学讨论
作者 : 秦 　祎, 廖 艺涵, 夏 　媛, 刘 振雨
DOI: 10.12361/2705-0459-04-08-97804
全部来源
获取全文
摘要 / Abstract
乳腺癌是发生在乳腺癌部位的肿瘤，往往都是恶性的，肿瘤的发生机制中，最重要的就是肿瘤的免疫逃逸， 肿瘤发生免疫逃逸后，人类的免疫系统往往无法对其进行监视，这就会导致肿瘤的扩散，细胞遗传学是研究肿瘤细 胞DNA与细胞增殖的基础，我们尝试对肿瘤细胞的DNA突变进行分析并得出结论，笔者结合卫生经济学进行讨论。
关键词 / Keywords
乳腺癌；免疫学；细胞遗传学；卫生经济学
Related articles / 相关文献
相似文献
作者发文
机构发文
关键词分析
相似文献（说明：与本文内容较接近的文献）
  • [1]Abdulkareem, Imran Haruna. “Aetio-pathogenesis of
  • breast cancer.” Nigerian medical journal: journal of the Nigeria
  • Medical Association 54.6 (2013): 371.
  • [2]Shah, Nirav R., and Hexin Chen. “MicroRNAs in
  • pathogenesis of breast cancer: Implications in diagnosis and
  • treatment.” World journal of clinical oncology 5.2 (2014): 48.
  • [3]Rahmani, Farzad, et al. “Role of regulatory miRNAs of
  • the PI3K/AKT signaling pathway in the pathogenesis of breast
  • cancer.” Gene 737 (2020): 144459.
  • [4]Bahreyni, Amirhossein, et al. “Role of adenosine
  • signaling in the pathogenesis of breast cancer.” Journal of
  • Cellular Physiology 233.3 (2018): 1836-1843.
  • [5]Sovak, Mika A., et al. “Aberrant nuclear factor_xfffe_kappaB/Rel expression and the pathogenesis of breast cancer.”
  • The Journal of clinical investigation 100.12 (1997): 2952-
  • 2960.
  • [6]Mukhopadhyay, P., Chakraborty, S., Ponnusamy, M.
  • P., Lakshmanan, I., Jain, M., & Batra, S. K. (2011). Mucins in
  • the pathogenesis of breast cancer: implications in diagnosis,
  • prognosis and therapy. Biochimica et Biophysica Acta (BBA)-
  • Reviews on Cancer, 1815(2), 224-240.
  • [7]King, Jeronay, Hina Mir, and Shailesh Singh.
  • “Association of cytokines and chemokines in pathogenesis
  • of breast cancer.” Progress in Molecular Biology and
  • Translational Science 151 (2017): 113-136.
  • [8]Niu, Tong, Weiwei Zhang, and Wei Xiao. “MicroRNA
  • regulation of cancer stem cells in the pathogenesis of breast
  • cancer.” Cancer Cell International 21.1 (2021): 1-14.
  • [9]Ghafouri-Fard, Soudeh, et al. “An update on the
  • role of long non-coding RNAs in the pathogenesis of breast
  • cancer.” Pathology-Research and Practice 219 (2021):
  • 153373.
  • [10]Khoshakhlagh, M., Soleimani, A., Binabaj, M. M.,
  • Avan, A., Ferns, G. A., Khazaei, M., & Hassanian, S. M. (2019).
  • Therapeutic potential of pharmacological TGF-β signaling
  • pathway inhibitors in the pathogenesis of breast cancer.
  • Biochemical Pharmacology, 164, 17-22.
  • [11]Daemen, Anneleen, et al. “Erratum to: Modeling
  • precision treatment of breast cancer.” Genome biology 16.1
  • (2015): 1-3.
  • [12]Zhang, Y., Zhang, D., Meng, Q., Liu, Z., Xie, H., Liu,
  • L., ... & Chen, X. (2021). Precision treatment exploration of
  • breast cancer based on heterogeneity analysis of lncRNAs at
  • the single-cell level. BMC cancer, 21(1), 1-15.
  • [13]Arnedos, M., Vicier, C., Loi, S., Lefebvre, C.,
  • Michiels, S., Bonnefoi, H., & Andre, F. (2015). Precision
  • medicine for metastatic breast cancer— limitations and
  • solutions. Nature reviews Clinical oncology, 12(12), 693-704.
《中国学术期刊(光盘版)》电子杂志社有限公司 KDN平台基础技术由KBASE 11.0提供
© 2014-2018中国知网(CNKI) 京公网安备11010802020460号 经营性网站备案信息 互联网出版许可证 新出网证(京)字271号 京ICP证040431号